{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:27:39Z","timestamp":1791685659062,"version":"4.3.4"},"reference-count":185,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Autistic spectrum disorder (ASD) is a complicated developmental disease characterized by\npersistent difficulties in social interaction, speech and nonverbal communication, and restricted\/\nrepetitive activities. Our goal is to deliver a step ahead awareness on neurodevelopment in ASD\nthrough early behavioral screenings, genetic testing, and detection of various environmental triggers.\nThis would significantly reduce the tally of people with autistic characteristics. As of now, much work\nis to be done in understanding and treating ASD. Firstly, awareness campaigns must be organized and\nmaintained so that ASD children can be identified and treated feasibly. Secondly, prenatal and prepregnancy\nenvironmental risk awareness, including advice against consanguineous marriages, information\non optimum mother nutrition, and minimizing pollutants exposure, can be focused. Finally, the\nextension of genetic screening along with early postnatal monitoring of newborn feeding, nutrition,\nand eye contact will help in early therapy. People with ASD have strict dietary habits, but they are also\nmore prone to gastrointestinal problems, including diarrhoea, constipation, and sometimes irritable\nbowel syndrome. Despite significant studies on the symptoms and possible causes of ASD, GI dysfunction\nis becoming a hot issue of discussion. Dietary strategies can partially help to alleviate both GI\nand behavioural issues due to the link between gut-microbiota and brain activity. Dietary treatments\nmay be less expensive, easier to administer and have fewer adverse effects than pharmacological interventions.\nHence, there is an increasing interest in autistic children's customized diets and supplements.\nFuture studies should look at whether these diets are applicable to diverse people and whether\nthey are practical in various circumstances (areas with fewer resources, lower socioeconomic areas,\ncountries with different dietary restrictions, etc.). The dietary phytochemicals, including curcumin,\nresveratrol, naringenin, and sulforaphane, have a substantial role as neurotherapeutic agents. These\nagents can act as an antioxidant, immunomodulator, gut microbiota modulator and Nrf2 activator to\nprovide benefits to ASD patients. Hence an urgent need is to create brain-targeted delivery methods\nfor these dietary phytochemicals and to investigate their therapeutic value in ASD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527321666220428134802","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T15:08:32Z","timestamp":1651331312000},"page":"659-677","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers,\nPharmacological and Non-Pharmacological Interventions"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8783-6876","authenticated-orcid":true,"given":"Sagarika","family":"Majhi","sequence":"first","affiliation":[{"name":"I.T.S College of Pharmacy, Muradnagar, Ghaziabad, India"},{"name":"Kharvel Subharti College of Pharmacy, Swami Vivekanand\nSubharti University, Meerut, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokindra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Kharvel Subharti College of Pharmacy, Swami Vivekanand\nSubharti University, Meerut, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubhan","family":"Singh","sequence":"additional","affiliation":[{"name":"Kharvel Subharti College of Pharmacy, Swami Vivekanand\nSubharti University, Meerut, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Bleuler E.","year":"1912","unstructured":"Bleuler E.; The theory of schizophrenic negativism. New York, Journal of Nervous and Mental Disease Pub Co 1912","journal-title":"New York, Journal of Nervous and Mental Disease Pub Co"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2006.07.025","volume":"176","author":"MacFabe D.F.","year":"2007","unstructured":"MacFabe D.F.; Cain D.P.; Rodriguez-Capote K.; Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 2007,176(1),149-169","journal-title":"Behav Brain Res"},{"key":"ref=3","year":"1980","unstructured":"Diagnostic and statistical manual of mental disorders American Psychiatric Association1980","journal-title":"Diagnostic and statistical manual of mental disorders"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","volume":"65","author":"Fombonne E.","year":"2009","unstructured":"Fombonne E.; Epidemiology of pervasive developmental disorders. Pediatr Res 2009,65(6),591-598","journal-title":"Pediatr Res"},{"key":"ref=5","first-page":"2","year":"2010","unstructured":"International statistical classification of diseases and related health problems. Instruction manual. ICD-102010,2"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1001\/archpsyc.63.6.694","volume":"63","author":"Lord C.","year":"2006","unstructured":"Lord C.; Risi S.; DiLavore P.S.; Shulman C.; Thurm A.; Pickles A.; Autism from 2 to 9 years of age. Arch Gen Psychiatry 2006,63(6),694-701","journal-title":"Arch Gen Psychiatry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/01.chi.0000227880.42780.0e","volume":"45","author":"Risi S.","year":"2006","unstructured":"Risi S.; Lord C.; Gotham K.; Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 2006,45(9),1094-1103","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=8","year":"2013","unstructured":"Diagnostic and statistical manual of mental disorders: DSM-5 American Psychiatric Publishing2013","journal-title":"Diagnostic and statistical manual of mental disorders: DSM-5"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1542\/peds.2010-2825","volume":"128","author":"Ozonoff S.","year":"2011","unstructured":"Ozonoff S.; Young G.S.; Carter A.; Recurrence risk for autism spectrum disorders: A baby siblings research consortium study. Pediatrics 2011,128(3),e488-e495","journal-title":"Pediatrics"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jaac.2012.02.018","volume":"51","author":"Sandin S.","year":"2012","unstructured":"Sandin S.; Hultman C.M.; Kolevzon A.; Gross R.; MacCabe J.H.; Reichenberg A.; Advancing maternal age is associated with increasing risk for autism: A review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2012,51(5),477-486.e1","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1352\/0895-8017(2004)109<237:PWACIM>2.0.CO;2","volume":"109","author":"Abbeduto L.","year":"2004","unstructured":"Abbeduto L.; Seltzer M.M.; Shattuck P.; Krauss M.W.; Orsmond G.; Murphy M.M.; Psychological well-being and coping in mothers of youths with autism, Down syndrome, or fragile X syndrome. Am J Ment Retard 2004,109(3),237-254","journal-title":"Am J Ment Retard"},{"key":"ref=12","first-page":"485","author":"Aggleton J.P.","year":"1992","unstructured":"Aggleton J.P.; The functional effects of amygdala lesions in humans: A comparison with findings from monkeys. The amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction 1992,485-503","journal-title":"The amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1152\/physrev.00002.2003","volume":"83","author":"Sah P.","year":"2003","unstructured":"Sah P.; Faber E.S.; Lopez De Armentia M.; Power J.; The amygdaloid complex: Anatomy and physiology. Physiol Rev 2003,83(3),803-834","journal-title":"Physiol Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","volume":"9","author":"Alexander G.E.","year":"1986","unstructured":"Alexander G.E.; DeLong M.R.; Strick P.L.; Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986,9(1),357-381","journal-title":"Annu Rev Neurosci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"Lai M.C.","year":"2014","unstructured":"Lai M.C.; Lombardo M.V.; Baron-Cohen S.; Autism. Lancet 2014,383(9920),896-910","journal-title":"Lancet"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature03086","volume":"433","author":"Adolphs R.","year":"2005","unstructured":"Adolphs R.; Gosselin F.; Buchanan T.W.; Tranel D.; Schyns P.; Damasio A.R.; A mechanism for impaired fear recognition after amygdala damage. Nature 2005,433(7021),68-72","journal-title":"Nature"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nn1413","volume":"8","author":"Adolphs R.","year":"2005","unstructured":"Adolphs R.; Tranel D.; Buchanan T.W.; Amygdala damage impairs emotional memory for gist but not details of complex stimuli. Nat Neurosci 2005,8(4),512-518","journal-title":"Nat Neurosci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1523\/JNEUROSCI.3789-06.2007","volume":"27","author":"Spezio M.L.","year":"2007","unstructured":"Spezio M.L.; Huang P.Y.; Castelli F.; Adolphs R.; Amygdala damage impairs eye contact during conversations with real people. J Neurosci 2007,27(15),3994-3997","journal-title":"J Neurosci"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199837755.001.0001","author":"Stuss D.T.","year":"2013","unstructured":"Stuss D.T.; Knight R.T.;  Principles of frontal lobe function 2013","journal-title":"Principles of frontal lobe function"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ana.20032","volume":"55","author":"Herbert M.R.","year":"2004","unstructured":"Herbert M.R.; Ziegler D.A.; Makris N.; Localization of white matter volume increase in autism and developmental language disorder. Ann Neurol 2004,55(4),530-540","journal-title":"Ann Neurol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1001\/jama.2011.1638","volume":"306","author":"Courchesne E.","year":"2011","unstructured":"Courchesne E.; Mouton P.R.; Calhoun M.E.; Neuron number and size in prefrontal cortex of children with autism. JAMA 2011,306(18),2001-2010","journal-title":"JAMA"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/jocn.1995.7.1.1","volume":"7","author":"Preuss T.M.","year":"1995","unstructured":"Preuss T.M.; Do rats have prefrontal cortex? The rose-woolsey-akert program reconsidered. J Cogn Neurosci 1995,7(1),1-24","journal-title":"J Cogn Neurosci"},{"key":"ref=23","author":"Finger S.","year":"2001","unstructured":"Finger S.;  Origins of neuroscience: A history of explorations into brain function 2001","journal-title":"Origins of neuroscience: A history of explorations into brain function"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/9780470996652.ch20","author":"Zelazo P.D.","year":"2002","unstructured":"Zelazo P.D.; Muller U.; Executive function in typical and atypical development. Handbook of childhood cognitive development. 2002,445-469"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11065-006-9002-x","volume":"16","author":"Alvarez J.A.","year":"2006","unstructured":"Alvarez J.A.; Emory E.; Executive function and the frontal lobes: A meta-analytic review. Neuropsychol Rev 2006,16(1),17-42","journal-title":"Neuropsychol Rev"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.neuro.051508.135535","volume":"32","author":"Robbins T.W.","year":"2009","unstructured":"Robbins T.W.; Arnsten A.F.; The neuropsychopharmacology of fronto-executive function: Monoaminergic modulation. Annu Rev Neurosci 2009,32(1),267-287","journal-title":"Annu Rev Neurosci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/npp.2008.222","volume":"34","author":"Cohen M.X.","year":"2009","unstructured":"Cohen M.X.; Axmacher N.; Lenartz D.; Elger C.E.; Sturm V.; Schlaepfer T.E.; Neuroelectric signatures of reward learning and decision-making in the human nucleus accumbens. Neuropsychopharmacology 2009,34(7),1649-1658","journal-title":"Neuropsychopharmacology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"RC159","DOI":"10.1523\/JNEUROSCI.21-16-j0002.2001","volume":"21","author":"Knutson B.","year":"2001","unstructured":"Knutson B.; Adams C.M.; Fong G.W.; Hommer D.; Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 2001,21(16),RC159","journal-title":"J Neurosci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.neuropsychologia.2004.05.011","volume":"42","author":"Ernst M.","year":"2004","unstructured":"Ernst M.; Nelson E.E.; McClure E.B.; Choice selection and reward anticipation: An fMRI study. Neuropsychologia 2004,42(12),1585-1597","journal-title":"Neuropsychologia"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neuroimage.2009.01.058","volume":"46","author":"Wacker J.","year":"2009","unstructured":"Wacker J.; Dillon D.G.; Pizzagalli D.A.; The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: Integration of resting EEG, fMRI, and volumetric techniques. Neuroimage 2009,46(1),327-337","journal-title":"Neuroimage"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/sj.npp.1301408","volume":"33","author":"Schlaepfer T.E.","year":"2008","unstructured":"Schlaepfer T.E.; Cohen M.X.; Frick C.; Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008,33(2),368-377","journal-title":"Neuropsychopharmacology"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0166-4328(01)00365-5","volume":"127","author":"Eichenbaum H.","year":"2001","unstructured":"Eichenbaum H.; The hippocampus and declarative memory: Cognitive mechanisms and neural codes. Behav Brain Res 2001,127(1-2),199-207","journal-title":"Behav Brain Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2049-9256-1-9","volume":"1","author":"Veinante P.","year":"2013","unstructured":"Veinante P.; Yalcin I.; Barrot M.; The amygdala between sensation and affect: A role in pain. J Mol Psychiatry 2013,1(1),9","journal-title":"J Mol Psychiatry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrn1033","volume":"4","author":"Wood J.N.","year":"2003","unstructured":"Wood J.N.; Grafman J.; Human prefrontal cortex: Processing and representational perspectives. Nat Rev Neurosci 2003,4(2),139-147","journal-title":"Nat Rev Neurosci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"11614","DOI":"10.1523\/JNEUROSCI.2335-09.2009","volume":"29","author":"Kim M.J.","year":"2009","unstructured":"Kim M.J.; Whalen P.J.; The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety. J Neurosci 2009,29(37),11614-11618","journal-title":"J Neurosci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/aur.122","volume":"3","author":"Scott-Van Zeeland A.A.","year":"2010","unstructured":"Scott-Van Zeeland A.A.; Dapretto M.; Ghahremani D.G.; Poldrack R.A.; Bookheimer S.Y.; Reward processing in autism. Autism Res 2010,3(2),53-67","journal-title":"Autism Res"},{"key":"ref=37","author":"Soorya L","unstructured":"Soorya L; Carpenter LA; El-Ghoroury NH; Diagnosing and managing autism: How psychologists help with autism spectrum disorder (ASD). 2017. Available from:  (Accessed on: 2021-10-09)."},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","year":"2001","unstructured":"Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther Biomarkers Definitions Working Group2001,69(3),89-95","journal-title":"Clin Pharmacol Ther"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/gim.2017.166","volume":"20","author":"Barton K.S.","year":"2018","unstructured":"Barton K.S.; Tabor H.K.; Starks H.; Garrison N.A.; Laurino M.; Burke W.; Pathways from autism spectrum disorder diagnosis to genetic testing. Genet Med 2018,20(7),737-744","journal-title":"Genet Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1038\/tp.2013.50","volume":"3","author":"Braunschweig D.","year":"2013","unstructured":"Braunschweig D.; Krakowiak P.; Duncanson P.; Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry 2013,3(7),e277","journal-title":"Transl Psychiatry"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/ajmg.b.30366","volume":"141B","author":"James S.J.","year":"2006","unstructured":"James S.J.; Melnyk S.; Jernigan S.; Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006,141B(8),947-956","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2217\/bmm-2017-0109","volume":"11","author":"Frye R.E.","year":"2017","unstructured":"Frye R.E.; Slattery J.C.; Quadros E.V.; Folate metabolism abnormalities in autism: Potential biomarkers. Biomarkers Med 2017,11(8),687-699","journal-title":"Biomarkers Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/ajmg.b.31094","volume":"153B","author":"James S.J.","year":"2010","unstructured":"James S.J.; Melnyk S.; Jernigan S.; A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism. Am J Med Genet B Neuropsychiatr Genet 2010,153B(6),1209-1220","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1192\/bjp.bp.108.051672","volume":"195","author":"Gardener H.","year":"2009","unstructured":"Gardener H.; Spiegelman D.; Buka S.L.; Prenatal risk factors for autism: Comprehensive meta-analysis. Br J Psychiatry 2009,195(1),7-14","journal-title":"Br J Psychiatry"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12888-018-1593-2","volume":"18","author":"Shen Y.","year":"2018","unstructured":"Shen Y.; Dong H.; Lu X.; Associations among maternal pre-pregnancy body mass index, gestational weight gain and risk of autism in the Han Chinese population. BMC Psychiatry 2018,18(1),11","journal-title":"BMC Psychiatry"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nature21369","volume":"542","author":"Hazlett H.C.","year":"2017","unstructured":"Hazlett H.C.; Gu H.; Munsell B.C.; Early brain development in infants at high risk for autism spectrum disorder. Nature 2017,542(7641),348-351","journal-title":"Nature"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-9-18","volume":"9","author":"Bosl W.","year":"2011","unstructured":"Bosl W.; Tierney A.; Tager-Flusberg H.; Nelson C.; EEG complexity as a biomarker for autism spectrum disorder risk. BMC Med 2011,9(1),18","journal-title":"BMC Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ajmg.b.32728","volume":"180","author":"Canfield M.A.","year":"2019","unstructured":"Canfield M.A.; Langlois P.H.; Rutenberg G.W.; The association between newborn screening analytes and childhood autism in a Texas Medicaid population, 2010-2012. Am J Med Genet B Neuropsychiatr Genet 2019,180(5),291-304","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"S673","DOI":"10.33549\/physiolres.933528","volume":"65","author":"Bujnakova I.","year":"2016","unstructured":"Bujnakova I.; Ondrejka I.; Mestanik M.; Autism spectrum disorder is associated with autonomic underarousal. Physiol Res 2016,65(Suppl. 5),S673-S682","journal-title":"Physiol Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2217\/bmm.13.158","volume":"8","author":"Frye R.E.","year":"2014","unstructured":"Frye R.E.; James S.J.; Metabolic pathology of autism in relation to redox metabolism. Biomarkers Med 2014,8(3),321-330","journal-title":"Biomarkers Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/mp.2012.126","volume":"19","author":"Skafidas E.","year":"2014","unstructured":"Skafidas E.; Testa R.; Zantomio D.; Chana G.; Everall I.P.; Pantelis C.; Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol Psychiatry 2014,19(4),504-510","journal-title":"Mol Psychiatry"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3389\/fgene.2018.00534","volume":"9","author":"Hicks S.D.","year":"2018","unstructured":"Hicks S.D.; Rajan A.T.; Wagner K.E.; Barns S.; Carpenter R.L.; Middleton F.A.; Validation of a Salivary RNA Test for Childhood Autism Spectrum Disorder. Front Genet 2018,9,534","journal-title":"Front Genet"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S2215-0366(18)30294-3","volume":"5","author":"Shen M.D.","year":"2018","unstructured":"Shen M.D.; Nordahl C.W.; Li D.D.; Extra-axial cerebrospinal fluid in high-risk and normal-risk children with autism aged 2-4 years: A case-control study. Lancet Psychiatry 2018,5(11),895-904","journal-title":"Lancet Psychiatry"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrg.2017.4","volume":"18","author":"Vorstman J.A.S.","year":"2017","unstructured":"Vorstman J.A.S.; Parr J.R.; Moreno-De-Luca D.; Anney R.J.L.; Nurnberger J.I.; Hallmayer J.F.; Autism genetics: Opportunities and challenges for clinical translation. Nat Rev Genet 2017,18(6),362-376","journal-title":"Nat Rev Genet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/aur.1755","volume":"10","author":"Amaral D.G.","year":"2017","unstructured":"Amaral D.G.; Li D.; Libero L.; In pursuit of neurophenotypes: The consequences of having autism and a big brain. Autism Res 2017,10(5),711-722","journal-title":"Autism Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/mp.2011.175","volume":"18","author":"Frye R.E.","year":"2013","unstructured":"Frye R.E.; Sequeira J.M.; Quadros E.V.; James S.J.; Rossignol D.A.; Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry 2013,18(3),369-381","journal-title":"Mol Psychiatry"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/MPG.0b013e3181dcc4a5","volume":"51","author":"de Magistris L.","year":"2010","unstructured":"de Magistris L.; Familiari V.; Pascotto A.; Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 2010,51(4),418-424","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"PI15","DOI":"10.12659\/MSM.881792","volume":"17","author":"Geier D.A.","year":"2011","unstructured":"Geier D.A.; Kern J.K.; Davis G.; A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Med Sci Monit 2011,17(6),PI15-PI23","journal-title":"Med Sci Monit"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"609705","DOI":"10.1155\/2013\/609705","volume":"2013","author":"Frye R.E.","year":"2013","unstructured":"Frye R.E.; Melnyk S.; Fuchs G.; Effectiveness of methylcobalamin and folinic Acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status. Autism Res Treat 2013,2013,609705","journal-title":"Autism Res Treat"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/mp.2016.168","volume":"23","author":"Frye R.E.","year":"2018","unstructured":"Frye R.E.; Slattery J.; Delhey L.; Folinic acid improves verbal communication in children with autism and language impairment: A randomized double-blind placebo-controlled trial. Mol Psychiatry 2018,23(2),247-256","journal-title":"Mol Psychiatry"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/13803395.2016.1252724","volume":"39","author":"Zamzow R.M.","year":"2017","unstructured":"Zamzow R.M.; Ferguson B.J.; Ragsdale A.S.; Lewis M.L.; Beversdorf D.Q.; Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers. J Clin Exp Neuropsychol 2017,39(6),596-606","journal-title":"J Clin Exp Neuropsychol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e872","DOI":"10.1038\/tp.2016.152","volume":"6","author":"Kosaka H.","year":"2016","unstructured":"Kosaka H.; Okamoto Y.; Munesue T.; Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: A 24-week randomized clinical trial. Transl Psychiatry 2016,6(8),e872","journal-title":"Transl Psychiatry"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"e1137","DOI":"10.1038\/tp.2017.104","volume":"7","author":"Ajram L.A.","year":"2017","unstructured":"Ajram L.A.; Horder J.; Mendez M.A.; Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder. Transl Psychiatry 2017,7(5),e1137","journal-title":"Transl Psychiatry"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamapsychiatry.2017.4685","volume":"75","author":"Muhle R.A.","year":"2018","unstructured":"Muhle R.A.; Reed H.E.; Stratigos K.A.; Veenstra-VanderWeele J.; The emerging clinical neuroscience of autism spectrum disorder: A review. JAMA Psychiatry 2018,75(5),514-523","journal-title":"JAMA Psychiatry"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ajmg.c.30078","volume":"142C","author":"Bacchelli E.","year":"2006","unstructured":"Bacchelli E.; Maestrini E.; Autism spectrum disorders: Molecular genetic advances. Am J Med Genet C Semin Med Genet 2006,142C(1),13-23","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/dmcn.13717","volume":"60","author":"Woodbury-Smith M.","year":"2018","unstructured":"Woodbury-Smith M.; Scherer S.W.; Progress in the genetics of autism spectrum disorder. Dev Med Child Neurol 2018,60(5),445-451","journal-title":"Dev Med Child Neurol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0959-4388(99)80050-6","volume":"9","author":"Harris K.M.","year":"1999","unstructured":"Harris K.M.; Structure, development, and plasticity of dendritic spines. Curr Opin Neurobiol 1999,9(3),343-348","journal-title":"Curr Opin Neurobiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1089071","volume":"302","author":"Zoghbi H.Y.","year":"2003","unstructured":"Zoghbi H.Y.; Postnatal neurodevelopmental disorders: Meeting at the synapse? Science 2003,302(5646),826-830","journal-title":"Science"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1073\/pnas.0711555105","volume":"105","author":"Jamain S.","year":"2008","unstructured":"Jamain S.; Radyushkin K.; Hammerschmidt K.; Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci USA 2008,105(5),1710-1715","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000334260","volume":"2","author":"Phelan K.","year":"2012","unstructured":"Phelan K.; McDermid H.E.; The 22q13.3 deletion syndrome (Phelan\u2013McDermid syndrome). Mol Syndromol 2012,2(3-5),186-201","journal-title":"Mol Syndromol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature09965","volume":"472","author":"Pe&#xE7;a J.","year":"2011","unstructured":"Pe&#xE7;a J.; Feliciano C.; Ting J.T.; Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011,472(7344),437-442","journal-title":"Nature"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.pediatrneurol.2010.05.022","volume":"43","author":"Gabis L.","year":"2010","unstructured":"Gabis L.; Raz R.; Kesner-Baruch Y.; Paternal age in autism spectrum disorders and ADHD. Pediatr Neurol 2010,43(4),300-302","journal-title":"Pediatr Neurol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1093\/hmg\/ddw328","volume":"25","author":"Atsem S.","year":"2016","unstructured":"Atsem S.; Reichenbach J.; Potabattula R.; Paternal age effects on sperm FOXK1 and KCNA7 methylation and transmission into the next generation. Hum Mol Genet 2016,25(22),4996-5005","journal-title":"Hum Mol Genet"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/npp.2016.158","volume":"42","author":"Meltzer A.","year":"2017","unstructured":"Meltzer A.; Van de Water J.; The role of the immune system in autism spectrum disorder. Neuropsychopharmacology 2017,42(1),284-298","journal-title":"Neuropsychopharmacology"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3717215","DOI":"10.1155\/2018\/3717215","volume":"2018","author":"Carpita B.","year":"2018","unstructured":"Carpita B.; Muti D.; Dell\u2019Osso L.; Oxidative stress, maternal diabetes, and autism spectrum disorders. Oxid Med Cell Longev 2018,2018,3717215","journal-title":"Oxid Med Cell Longev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s10803-017-3412-x","volume":"48","author":"Maeyama K.","year":"2018","unstructured":"Maeyama K.; Tomioka K.; Nagase H.; Congenital cytomegalovirus infection in children with autism spectrum disorder: Systematic review and meta-analysis. J Autism Dev Disord 2018,48(5),1483-1491","journal-title":"J Autism Dev Disord"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jamapsychiatry.2018.0854","volume":"75","author":"Maher G.M.","year":"2018","unstructured":"Maher G.M.; O\u2019Keeffe G.W.; Kearney P.M.; Association of hypertensive disorders of pregnancy with risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis. JAMA Psychiatry 2018,75(8),809-819","journal-title":"JAMA Psychiatry"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"e6696","DOI":"10.1097\/MD.0000000000006696","volume":"96","author":"Wang C.","year":"2017","unstructured":"Wang C.; Geng H.; Liu W.; Zhang G.; Prenatal, perinatal, and postnatal factors associated with autism: A meta-analysis. Medicine (Baltimore) 2017,96(18),e6696","journal-title":"Medicine (Baltimore)"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"e017248","DOI":"10.1136\/bmjopen-2017-017248","volume":"7","author":"Veroniki A.A.","year":"2017","unstructured":"Veroniki A.A.; Rios P.; Cogo E.; Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: A systematic review and network meta-analysis. BMJ Open 2017,7(7),e017248","journal-title":"BMJ Open"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"10418","DOI":"10.3390\/ijerph120910418","volume":"12","author":"Tang S.","year":"2015","unstructured":"Tang S.; Wang Y.; Gong X.; Wang G.; A meta-analysis of maternal smoking during pregnancy and autism spectrum disorder risk in offspring. Int J Environ Res Public Health 2015,12(9),10418-10431","journal-title":"Int J Environ Res Public Health"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1016\/j.vaccine.2014.04.085","volume":"32","author":"Taylor L.E.","year":"2014","unstructured":"Taylor L.E.; Swerdfeger A.L.; Eslick G.D.; Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies. Vaccine 2014,32(29),3623-3629","journal-title":"Vaccine"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"403","DOI":"10.31887\/DCNS.2017.19.4\/mdavidson","volume":"19","author":"Davidson M.","year":"2017","unstructured":"Davidson M.; Vaccination as a cause of autism-myths and controversies. Dialogues Clin Neurosci 2017,19(4),403-407","journal-title":"Dialogues Clin Neurosci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1363\/47e2615","volume":"47","author":"Cheslack Postava K.","year":"2015","unstructured":"Cheslack Postava K.; Winter A.S.; Short and long interpregnancy intervals: Correlates and variations by pregnancy timing among U.S. women. Perspect Sex Reprod Health 2015,47(1),19-26","journal-title":"Perspect Sex Reprod Health"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pnpbp.2017.07.011","volume":"79","author":"Saghazadeh A","year":"2017","unstructured":"Saghazadeh A; Rezaei N; Systematic review and meta-analysis links autism and toxic metals and highlights the impact of country development status: Higher blood and erythrocyte levels for mercury and lead, and higher hair antimony, cadmium, lead, and mercury. Prog Neuropsychopharmacol Biol Psychiatry 2017,79(Pt B),340-368","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/jhg.2013.49","volume":"58","author":"LaSalle J.M.","year":"2013","unstructured":"LaSalle J.M.; Epigenomic strategies at the interface of genetic and environmental risk factors for autism. J Hum Genet 2013,58(7),396-401","journal-title":"J Hum Genet"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"533.e1","DOI":"10.1016\/j.ajog.2015.02.011","volume":"212","author":"Behnia F.","year":"2015","unstructured":"Behnia F.; Parets S.E.; Kechichian T.; Fetal DNA methylation of autism spectrum disorders candidate genes: Association with spontaneous preterm birth. Am J Obstet Gynecol 2015,212(4),533.e1-533.e9","journal-title":"Am J Obstet Gynecol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature05915","volume":"447","author":"Berger S.L.","year":"2007","unstructured":"Berger S.L.; The complex language of chromatin regulation during transcription. Nature 2007,447(7143),407-412","journal-title":"Nature"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.biopsych.2008.08.015","volume":"65","author":"Akbarian S.","year":"2009","unstructured":"Akbarian S.; Huang H.S.; Epigenetic regulation in human brain-focus on histone lysine methylation. Biol Psychiatry 2009,65(3),198-203","journal-title":"Biol Psychiatry"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nn.3420","volume":"16","author":"Wang H.","year":"2013","unstructured":"Wang H.; Duclot F.; Liu Y.; Wang Z.; Kabbaj M.; Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles. Nat Neurosci 2013,16(7),919-924","journal-title":"Nat Neurosci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fneur.2016.00009","volume":"7","author":"Edmonson C.A.","year":"2016","unstructured":"Edmonson C.A.; Ziats M.N.; Rennert O.M.; A non-inflammatory role for microglia in autism spectrum disorders. Front Neurol 2016,7,9","journal-title":"Front Neurol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/glia.1112","volume":"36","author":"Bauer J.","year":"2001","unstructured":"Bauer J.; Rauschka H.; Lassmann H.; Inflammation in the nervous system: The human perspective. Glia 2001,36(2),235-243","journal-title":"Glia"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/glia.20082","volume":"47","author":"Ullian E.M.","year":"2004","unstructured":"Ullian E.M.; Christopherson K.S.; Barres B.A.; Role for glia in synaptogenesis. Glia 2004,47(3),209-216","journal-title":"Glia"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nrn916","volume":"3","author":"Nedergaard M.","year":"2002","unstructured":"Nedergaard M.; Takano T.; Hansen A.J.; Beyond the role of glutamate as a neurotransmitter. Nat Rev Neurosci 2002,3(9),748-755","journal-title":"Nat Rev Neurosci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.bbi.2011.08.007","volume":"26","author":"Onore C.","year":"2012","unstructured":"Onore C.; Careaga M.; Ashwood P.; The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2012,26(3),383-392","journal-title":"Brain Behav Immun"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","year":"2012","unstructured":"Structure, function and diversity of the healthy human microbiome. Nature Human Microbiome Project Consortium2012,486(7402),207-214","journal-title":"Nature"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","volume":"167","author":"Sharon G.","year":"2016","unstructured":"Sharon G.; Sampson T.R.; Geschwind D.H.; Mazmanian S.K.; The central nervous system and the gut microbiome. Cell 2016,167(4),915-932","journal-title":"Cell"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1600200","DOI":"10.1002\/bies.201600200","volume":"39","author":"Belcheva A.","year":"2017","unstructured":"Belcheva A.; MicroRNAs at the epicenter of intestinal homeostasis. BioEssays 2017,39(3),1600200","journal-title":"BioEssays"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"e103740","DOI":"10.1371\/journal.pone.0103740","volume":"9","author":"Nankova B.B.","year":"2014","unstructured":"Nankova B.B.; Agarwal R.; MacFabe D.F.; La Gamma E.F.; Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disorders. PLoS One 2014,9(8),e103740","journal-title":"PLoS One"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2012.77","volume":"18","author":"Clarke G.","year":"2013","unstructured":"Clarke G.; Grenham S.; Scully P.; The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013,18(6),666-673","journal-title":"Mol Psychiatry"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbr.2016.06.027","volume":"312","author":"Campos A.C.","year":"2016","unstructured":"Campos A.C.; Rocha N.P.; Nicoli J.R.; Vieira L.Q.; Teixeira M.M.; Teixeira A.L.; Absence of gut microbiota influences lipopolysaccharide-induced behavioral changes in mice. Behav Brain Res 2016,312,186-194","journal-title":"Behav Brain Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"Yano J.M.","year":"2015","unstructured":"Yano J.M.; Yu K.; Donaldson G.P.; Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015,161(2),264-276","journal-title":"Cell"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2672.2012.05344.x","volume":"113","author":"Barrett E","year":"2012","unstructured":"Barrett E; Ross RP; O\u2019Toole PW; Fitzgerald GF; Stanton C; &#x3B3;-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012,113(2),411-417","journal-title":"J Appl Microbiol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/bies.201100024","volume":"33","author":"Lyte M.","year":"2011","unstructured":"Lyte M.; Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics. BioEssays 2011,33(8),574-581","journal-title":"BioEssays"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00726-006-0477-9","volume":"33","author":"Blachier F.","year":"2007","unstructured":"Blachier F.; Mariotti F.; Huneau J.F.; Tom&#xE9; D.; Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 2007,33(4),547-562","journal-title":"Amino Acids"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"Loboda A.","year":"2016","unstructured":"Loboda A.; Damulewicz M.; Pyza E.; Jozkowicz A.; Dulak J.; Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cell Mol Life Sci 2016,73(17),3221-3247","journal-title":"Cell Mol Life Sci"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrc3278","volume":"12","author":"Sporn M.B.","year":"2012","unstructured":"Sporn M.B.; Liby K.T.; NRF2 and cancer: The good, the bad and the importance of context. Nat Rev Cancer 2012,12(8),564-571","journal-title":"Nat Rev Cancer"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.freeradbiomed.2014.03.025","volume":"71","author":"Levonen A.L.","year":"2014","unstructured":"Levonen A.L.; Hill B.G.; Kansanen E.; Zhang J.; Darley-Usmar V.M.; Redox regulation of antioxidants, autophagy, and the response to stress: Implications for electrophile therapeutics. Free Radic Biol Med 2014,71,196-207","journal-title":"Free Radic Biol Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.abb.2016.08.005","volume":"617","author":"Dinkova-Kostova A.T.","year":"2017","unstructured":"Dinkova-Kostova A.T.; Kostov R.V.; Canning P.; Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants. Arch Biochem Biophys 2017,617,84-93","journal-title":"Arch Biochem Biophys"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.abb.2016.10.010","volume":"617","author":"Sihvola V.","year":"2017","unstructured":"Sihvola V.; Levonen A.L.; Keap1 as the redox sensor of the antioxidant response. Arch Biochem Biophys 2017,617,94-100","journal-title":"Arch Biochem Biophys"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"4724920","DOI":"10.1155\/2019\/4724920","volume":"2019","author":"Habtemariam S.","year":"2019","unstructured":"Habtemariam S.; The Nrf2\/HO-1 axis as targets for flavanones: Neuroprotection by pinocembrin, naringenin, and eriodictyol. Oxid Med Cell Longev 2019,2019,4724920","journal-title":"Oxid Med Cell Longev"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1242\/bio.20134853","volume":"2","author":"Holmstr&#xF6;m K.M.","year":"2013","unstructured":"Holmstr&#xF6;m K.M.; Baird L.; Zhang Y.; Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol Open 2013,2(8),761-770","journal-title":"Biol Open"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-10-3007","volume":"71","author":"Kim T.H.","year":"2011","unstructured":"Kim T.H.; Hur E.G.; Kang S.J.; NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1&#x3B1;. Cancer Res 2011,71(6),2260-2275","journal-title":"Cancer Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2012.09.027","volume":"62","author":"Sultana R.","year":"2013","unstructured":"Sultana R.; Perluigi M.; Butterfield D.A.; Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med 2013,62,157-169","journal-title":"Free Radic Biol Med"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/ijms18010165","volume":"18","author":"Chirumbolo S.","year":"2017","unstructured":"Chirumbolo S.; Bj&#xF8;rklund G.; PERM hypothesis: The fundamental machinery able to elucidate the role of xenobiotics and hormesis in cell survival and homeostasis. Int J Mol Sci 2017,18(1),165","journal-title":"Int J Mol Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"257","DOI":"10.21307\/ane-2017-025","volume":"76","author":"Bjorklund G.","year":"2016","unstructured":"Bjorklund G.; Saad K.; Chirumbolo S.; Immune dysfunction and neuroinflammation in autism spectrum disorder. Acta Neurobiol Exp (Warsz) 2016,76(4),257-268","journal-title":"Acta Neurobiol Exp (Warsz)"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nbd.2015.04.020","volume":"84","author":"Cobb C.A.","year":"2015","unstructured":"Cobb C.A.; Cole M.P.; Oxidative and nitrative stress in neurodegeneration. Neurobiol Dis 2015,84,4-21","journal-title":"Neurobiol Dis"},{"key":"ref=117","first-page":"100","volume":"35","author":"Kanner L.","year":"1968","unstructured":"Kanner L.; Autistic disturbances of affective contact. Acta Paedopsychiatr 1968,35(4),100-136","journal-title":"Acta Paedopsychiatr"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2014.07.036","volume":"580","author":"Sabers A.","year":"2014","unstructured":"Sabers A.; Bertelsen F.C.; Scheel-Kr&#xFC;ger J.; Nyengaard J.R.; M&#xF8;ller A.; Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism. Neurosci Lett 2014,580,12-16","journal-title":"Neurosci Lett"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/ajmg.b.32222","volume":"165B","author":"Wang Z.","year":"2014","unstructured":"Wang Z.; Hong Y.; Zou L.; Reelin gene variants and risk of autism spectrum disorders: An integrated meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2014,165B(2),192-200","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/mp.2016.103","volume":"22","author":"Kim H.J.","year":"2017","unstructured":"Kim H.J.; Cho M.H.; Shim W.H.; Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects. Mol Psychiatry 2017,22(11),1576-1584","journal-title":"Mol Psychiatry"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12974-014-0189-0","volume":"11","author":"El-Ansary A.","year":"2014","unstructured":"El-Ansary A.; Al-Ayadhi L.; GABAergic\/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders. J Neuroinflammation 2014,11(1),189","journal-title":"J Neuroinflammation"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/cercor\/bhj069","volume":"16","author":"Hadjikhani N.","year":"2006","unstructured":"Hadjikhani N.; Joseph R.M.; Snyder J.; Tager-Flusberg H.; Anatomical differences in the mirror neuron system and social cognition network in autism. Cereb Cortex 2006,16(9),1276-1282","journal-title":"Cereb Cortex"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jneuroim.2005.11.007","volume":"172","author":"Molloy C.A.","year":"2006","unstructured":"Molloy C.A.; Morrow A.L.; Meinzen-Derr J.; Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006,172(1-2),198-205","journal-title":"J Neuroimmunol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11920-010-0097-7","volume":"12","author":"Gonzales M.L.","year":"2010","unstructured":"Gonzales M.L.; LaSalle J.M.; The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep 2010,12(2),127-134","journal-title":"Curr Psychiatry Rep"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1124\/dmd.115.063826","volume":"43","author":"Rosenfeld C.S.","year":"2015","unstructured":"Rosenfeld C.S.; Microbiome disturbances and autism spectrum disorders. Drug Metab Dispos 2015,43(10),1557-1571","journal-title":"Drug Metab Dispos"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.conb.2009.06.003","volume":"19","author":"Bourgeron T.","year":"2009","unstructured":"Bourgeron T.; A synaptic trek to autism. Curr Opin Neurobiol 2009,19(2),231-234","journal-title":"Curr Opin Neurobiol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fnins.2015.00313","volume":"9","author":"Subramanian M.","year":"2015","unstructured":"Subramanian M.; Timmerman C.K.; Schwartz J.L.; Pham D.L.; Meffert M.K.; Characterizing autism spectrum disorders by key biochemical pathways. Front Neurosci 2015,9,313","journal-title":"Front Neurosci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1073\/pnas.1112345109","volume":"109","author":"Veenstra-VanderWeele J.","year":"2012","unstructured":"Veenstra-VanderWeele J.; Muller C.L.; Iwamoto H.; Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci USA 2012,109(14),5469-5474","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1017\/S1461145712000715","volume":"16","author":"Bortolato M.","year":"2013","unstructured":"Bortolato M.; Godar S.C.; Alzghoul L.; Monoamine oxidase A and A\/B knockout mice display autistic-like features. Int J Neuropsychopharmacol 2013,16(4),869-888","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1097\/00004583-200312000-00005","volume":"42","author":"McClellan J.M.","year":"2003","unstructured":"McClellan J.M.; Werry J.S.; Evidence-based treatments in child and adolescent psychiatry: An inventory. J Am Acad Child Adolesc Psychiatry 2003,42(12),1388-1400","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4103\/0019-5359.25683","volume":"60","author":"Karande S.","year":"2006","unstructured":"Karande S.; Autism: A review for family physicians. Indian J Med Sci 2006,60(5),205-215","journal-title":"Indian J Med Sci"},{"key":"ref=132","first-page":"359","volume":"97","author":"McEachin J.J.","year":"1993","unstructured":"McEachin J.J.; Smith T.; Lovaas O.I.; Long-term outcome for children with autism who received early intensive behavioral treatment. Am J Ment Retard 1993,97(4),359-372","journal-title":"Am J Ment Retard"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2174\/13895575113136660100","volume":"13","author":"Raudenska M.","year":"2013","unstructured":"Raudenska M.; Gumulec J.; Babula P.; Haloperidol cytotoxicity and its relation to oxidative stress. Mini Rev Med Chem 2013,13(14),1993-1998","journal-title":"Mini Rev Med Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","volume":"60","author":"Nicoletti F.","year":"2011","unstructured":"Nicoletti F.; Bockaert J.; Collingridge G.L.; Metabotropic glutamate receptors: From the workbench to the bedside. Neuropharmacology 2011,60(7-8),1017-1041","journal-title":"Neuropharmacology"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yexmp.2016.05.012","volume":"101","author":"Stankovic M.S.","year":"2016","unstructured":"Stankovic M.S.; Janjetovic K.; Velimirovic M.; Effects of IL-33\/ST2 pathway in acute inflammation on tissue damage, antioxidative parameters, magnesium concentration and cytokines profile. Exp Mol Pathol 2016,101(1),31-37","journal-title":"Exp Mol Pathol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2019.01.005","volume":"125","author":"Zhao Q.","year":"2019","unstructured":"Zhao Q.; Wang Q.; Wang J.; Maternal immune activation-induced PPAR&#x3B3;-dependent dysfunction of microglia associated with neurogenic impairment and aberrant postnatal behaviors in offspring. Neurobiol Dis 2019,125,1-13","journal-title":"Neurobiol Dis"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejmech.2017.09.001","volume":"153","author":"Spagnuolo C.","year":"2018","unstructured":"Spagnuolo C.; Moccia S.; Russo G.L.; Anti-inflammatory effects of flavonoids in neurodegenerative disorders. Eur J Med Chem 2018,153,105-115","journal-title":"Eur J Med Chem"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0278-5846(93)90058-Z","volume":"17","author":"Dolske M.C.","year":"1993","unstructured":"Dolske M.C.; Spollen J.; McKay S.; Lancashire E.; Tolbert L.; A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry 1993,17(5),765-774","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00001163-199604000-00005","volume":"8","author":"Nickel R.E.","year":"1996","unstructured":"Nickel R.E.; Controversial therapies for young children with developmental disabilities. Infants Young Child 1996,8(4),29-40","journal-title":"Infants Young Child"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10803-010-1036-5","volume":"41","author":"Wright B.","year":"2011","unstructured":"Wright B.; Sims D.; Smart S.; Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: A randomised controlled crossover trial. J Autism Dev Disord 2011,41(2),175-184","journal-title":"J Autism Dev Disord"},{"key":"ref=141","first-page":"34","volume":"12","author":"Garvey J.","year":"2002","unstructured":"Garvey J.; Diet in autism and associated disorders. J Fam Health Care 2002,12(2),34-38","journal-title":"J Fam Health Care"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","volume":"80","author":"James S.J.","year":"2004","unstructured":"James S.J.; Cutler P.; Melnyk S.; Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004,80(6),1611-1617","journal-title":"Am J Clin Nutr"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.mehy.2006.09.064","volume":"68","author":"Rossignol D.A.","year":"2007","unstructured":"Rossignol D.A.; Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. Med Hypotheses 2007,68(6),1208-1227","journal-title":"Med Hypotheses"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.4088\/JCP.v67n1217","volume":"67","author":"Freeman M.P.","year":"2006","unstructured":"Freeman M.P.; Hibbeln J.R.; Wisner K.L.; Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006,67(12),1954-1967","journal-title":"J Clin Psychiatry"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41467-017-02794-5","volume":"9","author":"Wang J.","year":"2018","unstructured":"Wang J.; Hodes G.E.; Zhang H.; Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice. Nat Commun 2018,9(1),477","journal-title":"Nat Commun"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.3390\/ijms18091989","volume":"18","author":"Bahar E.","year":"2017","unstructured":"Bahar E.; Kim J.Y.; Yoon H.; Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS\/NF-&#x3BA;B and HO-1\/Nrf2 pathways. Int J Mol Sci 2017,18(9),1989","journal-title":"Int J Mol Sci"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijdevneu.2018.06.009","volume":"69","author":"Khalaj R.","year":"2018","unstructured":"Khalaj R.; Hajizadeh Moghaddam A.; Zare M.; Hesperetin and it nanocrystals ameliorate social behavior deficits and oxido-inflammatory stress in rat model of autism. Int J Dev Neurosci 2018,69(1),80-87","journal-title":"Int J Dev Neurosci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jff.2018.05.065","volume":"47","author":"Bhandari R.","year":"2018","unstructured":"Bhandari R.; Paliwal J.K.; Kuhad A.; Naringenin and its nanocarriers as potential phytotherapy for autism spectrum disorders. J Funct Foods 2018,47(2),361-375","journal-title":"J Funct Foods"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1523\/JNEUROSCI.3817-03.2004","volume":"24","author":"Kraft A.D.","year":"2004","unstructured":"Kraft A.D.; Johnson D.A.; Johnson J.A.; Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tertbutylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 2004,24(5),1101-1112","journal-title":"J Neurosci"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13229-018-0218-4","volume":"9","author":"Bent S.","year":"2018","unstructured":"Bent S.; Lawton B.; Warren T.; Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli. Mol Autism 2018,9(1),35","journal-title":"Mol Autism"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/antiox8020035","volume":"8","author":"Ginwala R.","year":"2019","unstructured":"Ginwala R.; Bhavsar R.; Chigbu D.I.; Jain P.; Khan Z.K.; Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants 2019,8(2),35","journal-title":"Antioxidants"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/nu10080979","volume":"10","author":"Kwon E.Y.","year":"2018","unstructured":"Kwon E.Y.; Kim S.Y.; Choi M.S.; Luteolin-enriched artichoke leaf extract alleviates the metabolic syndrome in mice with high-fat diet-induced obesity. Nutrients 2018,10(8),979","journal-title":"Nutrients"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408690390826464","volume":"43","author":"Higdon J.V.","year":"2003","unstructured":"Higdon J.V.; Frei B.; Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003,43(1),89-143","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.brainresbull.2018.07.012","volume":"142","author":"Ko Y.H.","year":"2018","unstructured":"Ko Y.H.; Kwon S.H.; Ma S.X.; The memory-enhancing effects of 7,8,4\u2032-trihydroxyisoflavone, a major metabolite of daidzein, are associated with activation of the cholinergic system and BDNF signaling pathway in mice. Brain Res Bull 2018,142,197-206","journal-title":"Brain Res Bull"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"e1800313","DOI":"10.1002\/mnfr.201800313","volume":"62","author":"L&#xF3;pez P.","year":"2018","unstructured":"L&#xF3;pez P.; S&#xE1;nchez M.; Perez-Cruz C.; Long-term genistein consumption modifies gut microbiota, improving glucose metabolism, metabolic endotoxemia, and cognitive function in mice fed a high-fat diet. Mol Nutr Food Res 2018,62(16),e1800313","journal-title":"Mol Nutr Food Res"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"6241017","DOI":"10.1155\/2018\/6241017","volume":"2018","author":"Enogieru A.B.","year":"2018","unstructured":"Enogieru A.B.; Haylett W.; Hiss D.C.; Bardien S.; Ekpo O.E.; Rutin as a potent antioxidant: Implications for neurodegenerative disorders. Oxid Med Cell Longev 2018,2018,6241017","journal-title":"Oxid Med Cell Longev"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fnsyn.2018.00009","volume":"10","author":"Fontes-Dutra M.","year":"2018","unstructured":"Fontes-Dutra M.; Santos-Terra J.; Deckmann I.; Resveratrol prevents cellular and behavioral sensory alterations in the animal model of autism induced by valproic acid. Front Synaptic Neurosci 2018,10,9","journal-title":"Front Synaptic Neurosci"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3945\/an.117.016261","volume":"8","author":"Poulose S.M.","year":"2017","unstructured":"Poulose S.M.; Miller M.G.; Scott T.; Shukitt-Hale B.; Nutritional factors affecting adult neurogenesis and cognitive function. Adv Nutr 2017,8(6),804-811","journal-title":"Adv Nutr"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbr.2014.04.045","volume":"270","author":"Pragnya B.","year":"2014","unstructured":"Pragnya B.; Kameshwari J.S.; Veeresh B.; Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB\/C mice. Behav Brain Res 2014,270,86-94","journal-title":"Behav Brain Res"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s11064-012-0717-1","volume":"37","author":"Sandhya T.","year":"2012","unstructured":"Sandhya T.; Sowjanya J.; Veeresh B.; Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochem Res 2012,37(5),1121-1131","journal-title":"Neurochem Res"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10578-012-0292-3","volume":"43","author":"Hasanzadeh E.","year":"2012","unstructured":"Hasanzadeh E.; Mohammadi M.R.; Ghanizadeh A.; A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders. Child Psychiatry Hum Dev 2012,43(5),674-682","journal-title":"Child Psychiatry Hum Dev"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"CE01","DOI":"10.7860\/JCDR\/2017\/23862.9969","volume":"11","author":"Habib S.S.","year":"2017","unstructured":"Habib S.S.; Al-Regaiey K.; Bashir S.; Iqbal M.; Role of endocannabinoids on neuroinflammation in autism spectrum disorder prevention. J Clin Diagn Res 2017,11(6),CE01-CE03","journal-title":"J Clin Diagn Res"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbr.2015.02.041","volume":"286","author":"Al-Amin M.M.","year":"2015","unstructured":"Al-Amin M.M.; Rahman M.M.; Khan F.R.; Zaman F.; Mahmud Reza H.; Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism. Behav Brain Res 2015,286,112-121","journal-title":"Behav Brain Res"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"3597209","DOI":"10.1155\/2016\/3597209","volume":"2016","author":"Madore C.","year":"2016","unstructured":"Madore C.; Leyrolle Q.; Lacabanne C.; Neuroinflammation in autism: Plausible role of maternal inflammation, dietary omega 3, and microbiota. Neural Plast 2016,2016,3597209","journal-title":"Neural Plast"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ejn.14224","volume":"49","author":"Aryal S.","year":"2019","unstructured":"Aryal S.; Hussain S.; Drevon C.A.; Omega-3 fatty acids regulate plasticity in distinct hippocampal glutamatergic synapses. Eur J Neurosci 2019,49(1),40-50","journal-title":"Eur J Neurosci"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/npp.2013.274","volume":"39","author":"Karvat G.","year":"2014","unstructured":"Karvat G.; Kimchi T.; Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism. Neuropsychopharmacology 2014,39(4),831-840","journal-title":"Neuropsychopharmacology"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.pbb.2011.02.003","volume":"100","author":"Carlson G.C.","year":"2012","unstructured":"Carlson G.C.; Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders. Pharmacol Biochem Behav 2012,100(4),850-854","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/0196-9781(83)90029-3","volume":"4","author":"Charlton C.G.","year":"1983","unstructured":"Charlton C.G.; Miller R.L.; Crawley J.N.; Handelmann G.E.; O\u2019Donohue T.L.; Secretin modulation of behavioral and physiological functions in the rat. Peptides 1983,4(5),739-742","journal-title":"Peptides"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mrdd.20031","volume":"10","author":"Symons F.J.","year":"2004","unstructured":"Symons F.J.; Thompson A.; Rodriguez M.C.; Self-injurious behavior and the efficacy of naltrexone treatment: A quantitative synthesis. Ment Retard Dev Disabil Res Rev 2004,10(3),193-200","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/YPG.0b013e3283643684","volume":"24","author":"Bakermans-Kranenburg M.J.","year":"2014","unstructured":"Bakermans-Kranenburg M.J.; van Ijzendoorn M.H.; A sociability gene? Meta-analysis of oxytocin receptor genotype effects in humans. Psychiatr Genet 2014,24(2),45-51","journal-title":"Psychiatr Genet"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1517\/14728222.2010.528394","volume":"14","author":"Villagonzalo K.A.","year":"2010","unstructured":"Villagonzalo K.A.; Dodd S.; Dean O.; Gray K.; Tonge B.; Berk M.; Oxidative pathways as a drug target for the treatment of autism. Expert Opin Ther Targets 2010,14(12),1301-1310","journal-title":"Expert Opin Ther Targets"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"e57380","DOI":"10.1371\/journal.pone.0057380","volume":"8","author":"Naviaux R.K.","year":"2013","unstructured":"Naviaux R.K.; Zolkipli Z.; Wang L.; Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model. PLoS One 2013,8(3),e57380","journal-title":"PLoS One"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nature11310","volume":"488","author":"Tsai P.T.","year":"2012","unstructured":"Tsai P.T.; Hull C.; Chu Y.; Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 2012,488(7413),647-651","journal-title":"Nature"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1517\/13543776.2013.768985","volume":"23","author":"Boosani C.S.","year":"2013","unstructured":"Boosani C.S.; Agrawal D.K.; PTEN modulators: A patent review. Expert Opin Ther Pat 2013,23(5),569-580","journal-title":"Expert Opin Ther Pat"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S1734-1140(12)70927-1","volume":"64","author":"Kumar B.","year":"2012","unstructured":"Kumar B.; Prakash A.; Sewal R.K.; Medhi B.; Modi M.; Drug therapy in autism: A present and future perspective. Pharmacol Rep 2012,64(6),1291-1304","journal-title":"Pharmacol Rep"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","volume":"68","author":"Morgan J.T.","year":"2010","unstructured":"Morgan J.T.; Chana G.; Pardo C.A.; Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 2010,68(4),368-376","journal-title":"Biol Psychiatry"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamapsychiatry.2013.272","volume":"70","author":"Suzuki K.","year":"2013","unstructured":"Suzuki K.; Sugihara G.; Ouchi Y.; Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 2013,70(1),49-58","journal-title":"JAMA Psychiatry"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"Vargas D.L.","year":"2005","unstructured":"Vargas D.L.; Nascimbene C.; Krishnan C.; Zimmerman A.W.; Pardo C.A.; Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005,57(1),67-81","journal-title":"Ann Neurol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10882-012-9268-2","volume":"24","author":"Chang Y.C.","year":"2012","unstructured":"Chang Y.C.; Quan J.; Wood J.J.; Effects of anxiety disorder severity on social functioning in children with autism spectrum disorders. J Dev Phys Disabil 2012,24(3),235-245","journal-title":"J Dev Phys Disabil"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1469-7610.2012.02606.x","volume":"54","author":"Simonoff E.","year":"2013","unstructured":"Simonoff E.; Jones C.R.; Baird G.; Pickles A.; Happ&#xE9; F.; Charman T.; The persistence and stability of psychiatric problems in adolescents with autism spectrum disorders. J Child Psychol Psychiatry 2013,54(2),186-194","journal-title":"J Child Psychol Psychiatry"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10882-017-9559-8","volume":"30","author":"Kose L.K.","year":"2018","unstructured":"Kose L.K.; Fox L.; Storch E.A.; Effectiveness of cognitive behavioral therapy for individuals with autism spectrum disorders and comorbid obsessive-compulsive disorder: A review of the research. J Dev Phys Disabil 2018,30(1),69-87","journal-title":"J Dev Phys Disabil"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","volume":"13","author":"Chauhan A.","year":"2006","unstructured":"Chauhan A.; Chauhan V.; Oxidative stress in autism. Pathophysiology 2006,13(3),171-181","journal-title":"Pathophysiology"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3945\/an.114.007914","volume":"6","author":"Ranjan S.","year":"2015","unstructured":"Ranjan S.; Nasser J.A.; Nutritional status of individuals with autism spectrum disorders: Do we know enough? Adv Nutr 2015,6(4),397-407","journal-title":"Adv Nutr"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.3390\/ijms21114159","volume":"21","author":"Abdellatif B.","year":"2020","unstructured":"Abdellatif B.; McVeigh C.; Bendriss G.; Chaari A.; The promising role of probiotics in managing the altered gut in autism spectrum disorders. Int J Mol Sci 2020,21(11),4159","journal-title":"Int J Mol Sci"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/1568026620666200131094445","volume":"20","author":"Anderson G.","year":"2020","unstructured":"Anderson G.; Maes M.; Gut dysbiosis dysregulates central and systemic homeostasis via suboptimal mitochondrial function: Assessment, treatment and classification implications. Curr Top Med Chem 2020,20(7),524-539","journal-title":"Curr Top Med Chem"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527321666220428134802","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204227\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527321666220428134802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T10:05:14Z","timestamp":1684836314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204227\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":185,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527321666220428134802","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}